Daxor Corporation (DXR)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Michael Richard Feldschuh | Chairman, President & CEO | 100k | -- | 1969 |
| Mr. Jonathan Adam Feldschuh | Chief Scientific Officer & Director | 127.92k | -- | 1965 |
| Ms. Linda Cooper | Vice President of Development & Operations | -- | -- | -- |
| Ms. Kathryn A. Kornafel | Senior VP of Marketing & Commercial Development | -- | -- | -- |
| Mr. Guido Manzo | Vice President of Sales | -- | -- | -- |
| Ms. Jean Oertel | Senior Vice President Commercialization & Customer Experience | -- | -- | -- |
| Dr. John Lynn Jefferies FACC, M.B.A., M.D., M.P.H. | Chief Medical Officer | -- | -- | -- |
Daxor Corporation
- Sector:
- Healthcare
- Industry: Medical Instruments & Supplies
Description
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.
Corporate Governance
Upcoming Events
March 25, 2024 at 10:59 AM UTC
Daxor Corporation Earnings Date
Recent Events
May 30, 2024 at 12:00 AM UTC
NPORT-P: Monthly Portfolio Investments Report on Form N- PORT (Public)
February 29, 2024 at 12:00 AM UTC
NT-NCSR: Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report)
November 24, 2023 at 12:00 AM UTC
NPORT-P: Monthly Portfolio Investments Report on Form N- PORT (Public)